Management of Neuropathic Pain

  • Andrew J. M. Boulton
  • Loretta Vileikyte


Neuropathic pain affects many areas of the patient’s life, so a multidisciplinary approach is essential in managing the ­condition. In many cases the clinical assessment will indicate the need for psychological or physical therapy in addition to standard pharmacological treatments. Similarly, support and information on practical measures – such as using a bed cradle to lift bedclothes off hyperaesthetic skin – often prove invaluable.


Neuropathic Pain Diabetic Neuropathy Isosorbide Dinitrate Painful Diabetic Neuropathy Cardiovascular Autonomic Neuropathy 


  1. 1.
    DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995;122:561-568.Google Scholar
  2. 2.
    Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. N Engl J Med. 1995;333:89-94.PubMedCrossRefGoogle Scholar
  3. 3.
    Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risks: the EuroDiab ID M complication study. Diabetologia. 1996;39:1377-1386.PubMedCrossRefGoogle Scholar
  4. 4.
    Oyibo S, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002;19:870-873.PubMedCrossRefGoogle Scholar
  5. 5.
    Kihara M, Zollman PJ, Smithson IL, et al. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol. 1994;226(6Pt 1):E980-E985.Google Scholar
  6. 6.
    Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreas ­transplantation on diabetic neuropathy. N Engl J Med. 1990;322:1031-1037.PubMedCrossRefGoogle Scholar
  7. 7.
    Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diab Care. 2007;30:2608-2612.CrossRefGoogle Scholar
  8. 8.
    Boulton AJM, Drury J, Clarke B, et al. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diab Care. 1982;5:386-390.CrossRefGoogle Scholar
  9. 9.
    McQuay H, Tramer M, Nye BA. A systemic review of antidepressants in neuropathic pain. Pain. 1996;68:217-227.PubMedCrossRefGoogle Scholar
  10. 10.
    Max MB. Antidepressants as analgesics. In: Fields HL, Liebeskind JC, eds. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Progress in Pain Research and Management (Vol 1). Seattle: IASP; 1994:229-246.Google Scholar
  11. 11.
    Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.PubMedCrossRefGoogle Scholar
  12. 12.
    Watson CP. The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain. 2000;16(2 suppl):S49-S55.PubMedGoogle Scholar
  13. 13.
    Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med. 2003;348:1243-1255.PubMedCrossRefGoogle Scholar
  14. 14.
    Boulton AJM, Malik RA, Arezzo JS, et al. Diabetic somatic neuropathies. Diab Care. 2004;27:1458-1486.CrossRefGoogle Scholar
  15. 15.
    Sindrup SH, Gram LF, Brosen K, et al. The SSRI paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135-144.PubMedCrossRefGoogle Scholar
  16. 16.
    Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547-552.PubMedCrossRefGoogle Scholar
  17. 17.
    Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs placebo in patients with diabetic neuropathy. Pain. 2005;116:109-118.PubMedCrossRefGoogle Scholar
  18. 18.
    Kajdasz DK, Iyengar S, Desaiah D, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther. 2007;29(suppl 2):536-546.Google Scholar
  19. 19.
    Basile AS, Janowsky A, Golembiowska K, et al. Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. J Pharmacol Exp Ther. 2007;321:1208-1225.PubMedCrossRefGoogle Scholar
  20. 20.
    Rull JA, Quibrera R, Gonzalez-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double-blind crossover trial. Diabetologia. 1969;5:215-218.PubMedCrossRefGoogle Scholar
  21. 21.
    Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther. 1977;22:196-199.PubMedGoogle Scholar
  22. 22.
    Kochar DK, Jain N, Agarwal RP, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes – a randomized placebo controlled study. Acta Neurol Scand. 2002;106:248-252.PubMedCrossRefGoogle Scholar
  23. 23.
    Vinik AI. Use of antiepileptic drugs in the treatment of chronic ­painful diabetic neuropathy. J Clin Endocrinol Metab. 2005;90:4936-4945.PubMedCrossRefGoogle Scholar
  24. 24.
    Backonja MM, Beydoun A, Edwards KR, et al. Gabapentin for symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998;280:1831-1836.PubMedCrossRefGoogle Scholar
  25. 25.
    Rowbotham M, Harden N, Stacey B, et al. The gabapentin study group. Gabapentin for the treatment of postherpetic neuralgia. JAMA. 1998;280:1837-1843.PubMedCrossRefGoogle Scholar
  26. 26.
    Backonja M, Glazman RI. Gabapentin dosing for neuropathic pain evidence from randomized placebo controlled clinical trials. Clin Ther. 2003;25:81-104.PubMedCrossRefGoogle Scholar
  27. 27.
    DIN-LINK data, Cegedim Strategic Data, October 2006. Data calculated based on prescriptions where dosing instructions are known.Google Scholar
  28. 28.
    Rosenstock J, Tuchman M, LaMoreau L, et al. Pregabalin for the treatment of painful diabetic neuropathy: a randomized, controlled trial. Pain. 2004;110:628-634.PubMedCrossRefGoogle Scholar
  29. 29.
    Richter RW, Portenoy R, Sharma M, et al. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005;6:253-260.PubMedCrossRefGoogle Scholar
  30. 30.
    Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63:2104-2110.PubMedGoogle Scholar
  31. 31.
    Serpell M. Recognising and treating neuropathic pain. Available at: Last accessed August 2007.
  32. 32.
    Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diab Care. 2008;31:1448-1454.CrossRefGoogle Scholar
  33. 33.
    Beydoun A, Kobetz SA, Carrazana EJ. Efficacy of oxcarbazepine in the treatment of diabetic neuropathy. Clin J Pain. 2004;20:174-178.PubMedCrossRefGoogle Scholar
  34. 34.
    Kochar DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind trial. Q J Med. 2004;97:33-38.Google Scholar
  35. 35.
    Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy. Neurology. 2001;57:505-509.PubMedGoogle Scholar
  36. 36.
    Edwards K, Glantz MJ, Button J, et al. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double-blind placebo-controlled study. Neurology. 2000;54(suppl 3):A81.Google Scholar
  37. 37.
    Rauck RL, Shaibani A, Biton V, et al. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007;23:150-158.PubMedCrossRefGoogle Scholar
  38. 38.
    Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev. 2008;24(suppl 1):S52-S57.PubMedCrossRefGoogle Scholar
  39. 39.
    Kastrup J, Petersen P, Dejard A, et al. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy. Pain. 1987;28:69-75.PubMedCrossRefGoogle Scholar
  40. 40.
    Dejgard A, Peterson P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1988;1:9-11.PubMedCrossRefGoogle Scholar
  41. 41.
    Oskarsson P, Lins PE, Ljunggren JG, et al. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diab Care. 1997;20:1594-1597.CrossRefGoogle Scholar
  42. 42.
    Jarvis B, Coukell AJ. Mexilitene: a review of its therapeutic use in painful diabetic neuropathy. Drugs. 1998;56:691-708.PubMedCrossRefGoogle Scholar
  43. 43.
    Foley K. Opioids and chronic neuropathic pain. N Engl J Med. 2003;348:1279-1281.PubMedCrossRefGoogle Scholar
  44. 44.
    Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842-1846.PubMedGoogle Scholar
  45. 45.
    Harati Y, Gooch C, Swenson M, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000;14:65-70.PubMedCrossRefGoogle Scholar
  46. 46.
    Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927-934.PubMedGoogle Scholar
  47. 47.
    Watson CPN, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71-78.PubMedCrossRefGoogle Scholar
  48. 48.
    Bansal D, Bhansali A, Hota D, et al. Amitriptyline vs pregabalin in painful diabetic neuropathy: a randomised double-blind clinical trial. Diabet Med. 2009;26:1019-1026.PubMedCrossRefGoogle Scholar
  49. 49.
    Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind randomised controlled crossover trial. Lancet. 2009;374:1252-1261.PubMedCrossRefGoogle Scholar
  50. 50.
    Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin: a meta analysis. Eur J Clin Pharmacol. 1994;46:517-522.PubMedCrossRefGoogle Scholar
  51. 51.
    Low PA, Opfer-Gehrking TL, Dyck PJ, et al. Double-blind placebo-controlled study of capsaicin cream in chronic distal painful polyneuropathy. Pain. 1995;62:163-168.PubMedCrossRefGoogle Scholar
  52. 52.
    Barbano RL, Herrman DN, Hart-Gouleau S, et al. Effectiveness, tolerability and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61:914-918.PubMedCrossRefGoogle Scholar
  53. 53.
    Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diab Care. 2002;25:1699-1703.CrossRefGoogle Scholar
  54. 54.
    Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of painful neuropathy. Diab Care. 2003;26:2697-2698.CrossRefGoogle Scholar
  55. 55.
    Abuaisha BB, Constanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998;39:115-121.PubMedCrossRefGoogle Scholar
  56. 56.
    Oyibo S, Breislin K, Boulton AJM. Electrical stimulation therapy through stocking electrodes for painful diabetic neuropathy: a double-blind controlled crossover study. Diabet Med. 2004;21:940-944.PubMedCrossRefGoogle Scholar
  57. 57.
    Zinman LH, Ngo M, Ng ET, et al. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diab Care. 2004;27:921-924.CrossRefGoogle Scholar
  58. 58.
    Hamza MA, White PF, Craig WF, et al. Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diab Care. 2000;23:365-370.CrossRefGoogle Scholar
  59. 59.
    Weintraub MI, Wolfe GI, Baronh RA, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo controlled trial. Arch Phys Med Rehabil. 2003;84:736-746.PubMedCrossRefGoogle Scholar
  60. 60.
    Leonard DR, Farooqu MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double blind, randomized placebo-controlled study with monochromatic infrared treatment. Diab Care. 2004;27:168-172.CrossRefGoogle Scholar
  61. 61.
    Tesfaye S, Watt J, Benbow SJ, et al. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet. 1996;348:1698-1701.PubMedCrossRefGoogle Scholar
  62. 62.
    Daousi C, Benbow SJ, Macfarlane IA. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med. 2005;22:393-398.PubMedCrossRefGoogle Scholar
  63. 63.
    Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab Care. 2005;28:956-962.CrossRefGoogle Scholar
  64. 64.
    Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ. 2009;339:B3002.PubMedCrossRefGoogle Scholar
  65. 65.
    Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain – consenus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12:13-21.PubMedGoogle Scholar
  66. 66.
    Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153-1169.PubMedCrossRefGoogle Scholar
  67. 67.
    NICE Clinical Guideline 96: Neuropathic Pain. The pharmacological management of neuropathic pain in adults and in a non-specialist settings. Available at: Accessed March 2010.
  68. 68.
    Boulton AJM. NICE guidelines of the management of painful diabetic neuropathy. Pract Diabetes Int. 2010;27:1-2.CrossRefGoogle Scholar
  69. 69.
    Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diab Care. 2010;33:2285-2293.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Andrew J. M. Boulton
    • 1
    • 2
  • Loretta Vileikyte
    • 1
    • 3
  1. 1.University of ManchesterManchesterUK
  2. 2.Diabetes Research InstituteUniversity of MiamiMiamiUSA
  3. 3.University of MiamiMiamiUSA

Personalised recommendations